Ignite Creation Date:
2025-12-24 @ 9:39 PM
Ignite Modification Date:
2025-12-25 @ 7:21 PM
Study NCT ID:
NCT03954132
Status:
COMPLETED
Last Update Posted:
2024-04-24
First Post:
2019-05-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-15
First Submit QC Date:
None
Study First Post Date:
2019-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-26
Results First Submit QC Date:
None
Results First Post Date:
2024-03-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-18
Last Update Post Date:
2024-04-24
Last Update Post Date Type:
ACTUAL